Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Motus Gi Holdings Inc (MOTS)

Motus Gi Holdings Inc (MOTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,232
  • Shares Outstanding, K 2,753
  • Annual Sales, $ 390 K
  • Annual Income, $ -19,030 K
  • 60-Month Beta 1.96
  • Price/Sales 28.73
  • Price/Cash Flow N/A
  • Price/Book 1.30
Trade MOTS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -2.09
  • Number of Estimates 3
  • High Estimate -1.66
  • Low Estimate -2.40
  • Prior Year -2.00
  • Growth Rate Est. (year over year) -4.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.85 +2.61%
on 08/01/22
6.00 -34.17%
on 07/20/22
-1.72 (-30.34%)
since 07/08/22
3-Month
3.85 +2.61%
on 08/01/22
6.60 -40.15%
on 05/10/22
-1.47 (-27.09%)
since 05/06/22
52-Week
3.85 +2.61%
on 08/01/22
18.19 -78.28%
on 08/12/21
-13.58 (-77.47%)
since 08/06/21

Most Recent Stories

More News
Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TRHC : 5.08 (-1.74%)
MOTS : 3.95 (-3.19%)
Motus GI Holdings, Inc. (MOTS) Expected to Beat Earnings Estimates: Should You Buy?

Motus GI Holdings, Inc. (MOTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MOTS : 3.95 (-3.19%)
HIMS : 6.66 (+1.68%)
Motus GI Announces 1-FOR-20 Reverse Stock Split

FORT LAUDERDALE, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 3.95 (-3.19%)
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11

FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 3.95 (-3.19%)
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE,...

MOTS : 3.95 (-3.19%)
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong procedural volumes and significant positive feedback...

MOTS : 3.95 (-3.19%)
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

MDRX : 17.44 (-0.51%)
MOTS : 3.95 (-3.19%)
Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MOTS : 3.95 (-3.19%)
Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 3.95 (-3.19%)
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

MOTS : 3.95 (-3.19%)
PHR : 26.39 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also...

See More

Key Turning Points

3rd Resistance Point 4.36
2nd Resistance Point 4.27
1st Resistance Point 4.18
Last Price 3.95
1st Support Level 3.99
2nd Support Level 3.89
3rd Support Level 3.80

See More

52-Week High 18.19
Fibonacci 61.8% 12.71
Fibonacci 50% 11.02
Fibonacci 38.2% 9.33
Last Price 3.95
52-Week Low 3.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar